The collision between the “volume-to-value” movement and the pharmaceutical and biotech industries over the next few years will have a powerful impact on them and on the healthcare industry and on us as customers, patients, and payers. On the one hand, pharma is...
I talk to people all the time in health care at big civic gatherings; board retreats; conventions of nurses, physicians, managers of medical groups and accountable care organizations and health plans and device manufacturers. I give a talk, sit on a panel, run a...
By now, you have likely heard analyses of last week’s Obamacare-killer King v. Burwell Supreme Court case. But what will make a real difference to you and your organization? Here are the three things you most need to know about the case: Which outcome you should be...
There are no winners in the fee-for-service game. It’s time to toss the whole business-as-usual model — for your own good and the good of your customers. The emerging Default Model of health care — the “consumer-directed” insured fee-for-service model in which health...
So you spent millions to billions of dollars on information systems over the past few years, right? How’s that working out for you? For a large percentage of you, whether or not you admit it, not so well. What you bought needs some serious tweaks, re-engineering,...
Health care is fragile. It survives in a much narrower band of circumstances than most of us realize. Right now many hospitals and systems are having a second down year in a row. They’re consolidating, laying off people, working through major shifts in strategy — all...
